Kingstad-Bakke B, Lee W, Yount Jr B, Cleven T, Park H, Sullivan J
Commun Biol. 2025; 8(1):392.
PMID: 40057586
PMC: 11890755.
DOI: 10.1038/s42003-025-07820-7.
Schniederova M, Bobcakova A, Grendar M, Markocsy A, Ceres A, Cibulka M
Medicina (Kaunas). 2025; 61(2).
PMID: 40005306
PMC: 11857393.
DOI: 10.3390/medicina61020189.
He L, Wang Y, Yuan F, Morrissey S, Geller A, Hu X
Cells. 2025; 14(4).
PMID: 39996729
PMC: 11853107.
DOI: 10.3390/cells14040256.
Li B, Sha Z, Mou L, Zhang F, Jia L, Zhu Y
Front Immunol. 2025; 16:1519023.
PMID: 39991160
PMC: 11842381.
DOI: 10.3389/fimmu.2025.1519023.
Kaur R, Rawat D, William A, Kumar Singh P, Kandir N, Sharma A
Access Microbiol. 2025; 7(1).
PMID: 39882016
PMC: 11777003.
DOI: 10.1099/acmi.0.000640.v5.
Chordoma Spontaneous Regression After COVID-19.
Silva Junior L, Silva G, Garcia Campos M, Teixeira Junior A, Santos R, Santos O
Viruses. 2025; 17(1).
PMID: 39861800
PMC: 11769020.
DOI: 10.3390/v17010010.
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.
Snyder T, Gittelman R, Klinger M, May D, Osborne E, Taniguchi R
Front Immunol. 2025; 15():1488860.
PMID: 39840037
PMC: 11747429.
DOI: 10.3389/fimmu.2024.1488860.
Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease.
Meggyes M, Nagy D, Toth I, Feik T, Peterfalvi A, Polgar B
Front Microbiol. 2025; 15:1508423.
PMID: 39764446
PMC: 11700970.
DOI: 10.3389/fmicb.2024.1508423.
A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals.
Missailidis D, Ebrahimie E, Dehcheshmeh M, Allan C, Sanislav O, Fisher P
Front Immunol. 2024; 15:1450853.
PMID: 39691709
PMC: 11649547.
DOI: 10.3389/fimmu.2024.1450853.
Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections.
Singh T, Macintyre A, Burke T, Anderson J, Petzold E, Stover E
Front Immunol. 2024; 15:1468871.
PMID: 39650666
PMC: 11621060.
DOI: 10.3389/fimmu.2024.1468871.
Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 Patients.
de Oliveira G, Costa-Rocha I, Oliveira-Carvalho N, Dos Santos T, Campi-Azevedo A, Peruhype-Magalhaes V
Microorganisms. 2024; 12(11).
PMID: 39597661
PMC: 11596994.
DOI: 10.3390/microorganisms12112272.
BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.
Paran F, Oyama R, Khasawneh A, Ai T, Ismanto H, Sherif A
Front Immunol. 2024; 15:1405013.
PMID: 39530088
PMC: 11550956.
DOI: 10.3389/fimmu.2024.1405013.
Immunology of Stress: A Review Article.
Alotiby A
J Clin Med. 2024; 13(21).
PMID: 39518533
PMC: 11546738.
DOI: 10.3390/jcm13216394.
SARS-CoV-2 infection elucidates features of pregnancy-specific immunity.
Oh D, Kim E, Normand R, Lu G, Shook L, Lyall A
Cell Rep. 2024; 43(11):114933.
PMID: 39504241
PMC: 11724703.
DOI: 10.1016/j.celrep.2024.114933.
Identifying T-cell clubs by embracing the local harmony between TCR and gene expressions.
Zou Y, Luo J, Chen L, Wang X, Liu W, Wang R
Mol Syst Biol. 2024; 20(12):1329-1345.
PMID: 39496799
PMC: 11612385.
DOI: 10.1038/s44320-024-00070-5.
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression.
Medina M, Fuentes-Villalobos F, Quevedo C, Aguilera F, Riquelme R, Rioseco M
Elife. 2024; 13.
PMID: 39470726
PMC: 11521369.
DOI: 10.7554/eLife.94242.
Immune exhaustion in ME/CFS and long COVID.
Eaton-Fitch N, Rudd P, Er T, Hool L, Herrero L, Marshall-Gradisnik S
JCI Insight. 2024; 9(20).
PMID: 39435656
PMC: 11529985.
DOI: 10.1172/jci.insight.183810.
Neuropeptide signalling orchestrates T cell differentiation.
Hou Y, Sun L, LaFleur M, Huang L, Lambden C, Thakore P
Nature. 2024; 635(8038):444-452.
PMID: 39415015
DOI: 10.1038/s41586-024-08049-w.
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.
Paranga T, Pavel-Tanasa M, Constantinescu D, Iftimi E, Plesca C, Miftode I
Front Immunol. 2024; 15:1464480.
PMID: 39376569
PMC: 11456479.
DOI: 10.3389/fimmu.2024.1464480.
Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.
Braga G, Francisco G, Bagatini M
J Mol Med (Berl). 2024; 102(10):1187-1198.
PMID: 39212718
DOI: 10.1007/s00109-024-02481-1.